Soluble receptor for advanced glycation end products is associated with in-stent restenosis in patients with type 2 diabetes with drug-eluting coronary stents
Hun‐Jun Park(Soonchunhyang University), Ki‐Dong Yoo(The Catholic University of Korea St. Vincent's Hospital), Sang Hong Baek(University of California, Los Angeles), Ki‐Bae Seung, Suk Min Seo(The Catholic University of Korea Incheon St. Mary's Hospital), Sung-Gyu Youn(St. Mary’s Hospital), Yoon Seok Choi(The Catholic University of Korea Yeouido St. Mary's Hospital), Mahn Won Park(The Catholic University of Korea Daejeon St. Mary's Hospital), Yoon Seok Koh(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Wook Sung Chung(The Catholic University of Korea Seoul St. Mary's Hospital), Hae-Ok Jung(The Catholic University of Korea Seoul St. Mary's Hospital), Woo Seung Shin, Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Pum Joon Kim(St. Paul's Hospital), Kiyuk Chang(St. Mary's Hospital)
Cited by 10
Related Papers
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493